1. Home
  2. ALRS vs CSTL Comparison

ALRS vs CSTL Comparison

Compare ALRS & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALRS
  • CSTL
  • Stock Information
  • Founded
  • ALRS 1879
  • CSTL 2007
  • Country
  • ALRS United States
  • CSTL United States
  • Employees
  • ALRS N/A
  • CSTL N/A
  • Industry
  • ALRS Major Banks
  • CSTL Medical Specialities
  • Sector
  • ALRS Finance
  • CSTL Health Care
  • Exchange
  • ALRS Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • ALRS 572.8M
  • CSTL 555.8M
  • IPO Year
  • ALRS 2019
  • CSTL 2019
  • Fundamental
  • Price
  • ALRS $21.60
  • CSTL $20.09
  • Analyst Decision
  • ALRS Hold
  • CSTL Strong Buy
  • Analyst Count
  • ALRS 5
  • CSTL 6
  • Target Price
  • ALRS $25.30
  • CSTL $37.67
  • AVG Volume (30 Days)
  • ALRS 95.5K
  • CSTL 702.0K
  • Earning Date
  • ALRS 07-28-2025
  • CSTL 08-04-2025
  • Dividend Yield
  • ALRS 3.89%
  • CSTL N/A
  • EPS Growth
  • ALRS 350.15
  • CSTL N/A
  • EPS
  • ALRS 1.59
  • CSTL N/A
  • Revenue
  • ALRS $252,130,000.00
  • CSTL $346,269,000.00
  • Revenue This Year
  • ALRS $40.80
  • CSTL N/A
  • Revenue Next Year
  • ALRS $3.69
  • CSTL $1.62
  • P/E Ratio
  • ALRS $13.56
  • CSTL N/A
  • Revenue Growth
  • ALRS 53.68
  • CSTL 20.40
  • 52 Week Low
  • ALRS $15.78
  • CSTL $14.59
  • 52 Week High
  • ALRS $24.41
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • ALRS 50.55
  • CSTL 62.20
  • Support Level
  • ALRS $20.33
  • CSTL $18.99
  • Resistance Level
  • ALRS $22.19
  • CSTL $20.18
  • Average True Range (ATR)
  • ALRS 0.70
  • CSTL 0.95
  • MACD
  • ALRS 0.07
  • CSTL 0.37
  • Stochastic Oscillator
  • ALRS 35.83
  • CSTL 81.57

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: